| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/10/2009 | WO2009129149A3 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
| 12/10/2009 | WO2009129147A3 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation |
| 12/10/2009 | WO2009127922A3 Pharmaceutical formulation for treating cardiovascular disease |
| 12/10/2009 | WO2009126950A3 Diterpene glycosides as natural solubilizers |
| 12/10/2009 | WO2009120887A3 Compositions and methods for tissue-specific rnai delivery in vivo |
| 12/10/2009 | WO2009117418A3 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 12/10/2009 | WO2009109990A3 Pramipexole composition comprising sugar alcohol(s) |
| 12/10/2009 | WO2009097443A3 Liquid formulations of compounds active at sulfonylurea receptors |
| 12/10/2009 | WO2009073524A3 Conjugates of anti-rg-1 antibodies |
| 12/10/2009 | WO2009060086A3 Increase of immune response and targeting by antigens and/or drug linkage |
| 12/10/2009 | WO2008070149A3 Prodrugs and methods of making and using the same |
| 12/10/2009 | US20090306228 Active agent delivery systems and methods for protecting and administering active agents |
| 12/10/2009 | US20090306227 Tablet for removing tongue coating |
| 12/10/2009 | US20090306226 Procedures for obtaining polymers derived from vinyl acetate and their uses |
| 12/10/2009 | US20090306225 Auris formulations for treating otic diseases and conditions |
| 12/10/2009 | US20090306224 Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 12/10/2009 | US20090306223 Surface-Active Material and Its Application |
| 12/10/2009 | US20090306198 Anti-Oxidant Synergy Formulation Nanoemulsions to Treat Caner |
| 12/10/2009 | US20090306120 Terpolymers containing lactide and glycolide |
| 12/10/2009 | US20090306036 Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter |
| 12/10/2009 | US20090306012 Therapeutic protocols |
| 12/10/2009 | US20090305952 Anionic polyamide functionalized with a tryptophan unit |
| 12/10/2009 | US20090305948 Branched Polyamino Acids Functionalized with Hydrophobic Groups, and Applications Thereof Particularly Therapeutic Applications |
| 12/10/2009 | US20090305411 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 12/10/2009 | US20090304824 Rapid-Melt Compositions, Methods of Making Same and Methods of Using Same |
| 12/10/2009 | US20090304804 Biologic devices for hemostasis |
| 12/10/2009 | US20090304795 Tablets with improved drug substance dispersibility |
| 12/10/2009 | US20090304775 Drug-Exuding Orthopedic Implant |
| 12/10/2009 | US20090304767 Bio-Degradable Block Co-Polymers for Controlled Release |
| 12/10/2009 | US20090304748 Clostridial toxin pharmaceutical compositions |
| 12/10/2009 | US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions |
| 12/10/2009 | US20090304744 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof |
| 12/10/2009 | US20090304723 Mono-and disaccharide derivatives |
| 12/10/2009 | US20090304720 Active Agent-Loaded Nanoparticles Based On Hydrophilic Proteins |
| 12/10/2009 | US20090304702 Gene expressed in prostate cancer and methods of use |
| 12/10/2009 | US20090304601 Method of marking a composition for use in oral administration |
| 12/10/2009 | US20090301363 Self-contained Heating Unit and Drug-Supply Unit Employing Same |
| 12/10/2009 | CA2726949A1 Stimuli-responsive hydrogel |
| 12/10/2009 | CA2726942A1 Fviii muteins for treatment of von willebrand disease |
| 12/10/2009 | CA2726890A1 Creamy o/w emulsion composition and production process thereof |
| 12/10/2009 | CA2726804A1 Xbp1, cd138, and cs1 peptides |
| 12/10/2009 | CA2726763A1 Controlled release copolymer formulation with improved release kinetics |
| 12/10/2009 | CA2726662A1 A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k |
| 12/10/2009 | CA2726648A1 Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 12/10/2009 | CA2726641A1 Nasal formulations of insulin |
| 12/10/2009 | CA2726589A1 Fgf21 mutants and uses thereof |
| 12/10/2009 | CA2726267A1 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative |
| 12/09/2009 | EP2130900A1 Method for producing a water-alcohol solution |
| 12/09/2009 | EP2130837A1 Novel nuclear translocation peptide |
| 12/09/2009 | EP2130555A1 Stimuli-responsive hydrogel |
| 12/09/2009 | EP2130554A1 Novel albumin-free factor VIII formulations |
| 12/09/2009 | EP2130549A1 Solid fibrinogen preparation |
| 12/09/2009 | EP2130542A1 Broad-spectrum antiviral composition having excellent storage stability |
| 12/09/2009 | EP2130539A1 Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia |
| 12/09/2009 | EP2129693A2 Shortened purification process for the production of capsularstreptococcus pneumoniae polysaccharides |
| 12/09/2009 | EP2129403A2 Bispecific fusion protein having therapeutic and diagnostic potential |
| 12/09/2009 | EP2129402A2 Receptor and antigen targeted prodrug |
| 12/09/2009 | EP2129401A2 Stable buffered formulations containing polypeptides |
| 12/09/2009 | EP2129365A1 Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use |
| 12/09/2009 | EP2129364A2 Process for manufacturing ophthalmic oil-in-water emulsions |
| 12/09/2009 | EP2129362A2 Personal care product comprising cyclodextrin as fragrance-complexing material |
| 12/09/2009 | EP1786841B1 Ultrasound-assisted synthesis of cyclodextrin-based nanosponges |
| 12/09/2009 | EP1722802B1 A medical solution, a method for producing said medical solution and use thereof |
| 12/09/2009 | EP1689425B1 Pharmaceutical formulations for the sustained release of one or more active principles and therapeutic applications thereof |
| 12/09/2009 | EP1518517B1 Drug-delivery endovascular stent |
| 12/09/2009 | EP0959905B1 Polysaccharide-peptide-conjugates |
| 12/09/2009 | CN201356819Y Allergy-free supplemented patch |
| 12/09/2009 | CN201356817Y Coptis-coated insulin granule |
| 12/09/2009 | CN101600459A Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 12/09/2009 | CN101600457A Anti-IL-13 antibody formulations and uses thereof |
| 12/09/2009 | CN101600431A Pharmaceutical composition having improved storage stability |
| 12/09/2009 | CN101600430A Solid medicinal preparation containing mannitol or lactose |
| 12/09/2009 | CN101597338A Mannan-containing ligand and preparation method and application thereof |
| 12/09/2009 | CN101597337A Conjugate of hydroxyalkyl starch and an active agent |
| 12/09/2009 | CN101596320A Medicament for treating tumor and application thereof |
| 12/09/2009 | CN101596319A Medicinal core pellet |
| 12/09/2009 | CN101596311A Stable kallikrein-1 injection |
| 12/09/2009 | CN101596310A Artificial substrate membrane emulsifying paste for wound surface restoration |
| 12/09/2009 | CN101596309A Pharmaceutical composition for preventing and treating livestock and poultry viral disease and effervescing agent prepared by same |
| 12/09/2009 | CN101596306A Pharmaceutical formulations for sustained drug delivery |
| 12/09/2009 | CN101596300A Traditional Chinese medicine sharpening-mind and inducing-consciousness microemulsion nasal cavity spraying agent and preparation method thereof |
| 12/09/2009 | CN101596298A Traditional Chinese drop pills for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 12/09/2009 | CN101596294A Emulsification adlay oil capable of inhibiting cholesterin and enhancing high-density lipoprotein and manufacture method thereof |
| 12/09/2009 | CN101596266A New article for treating dermatosis and preparation method |
| 12/09/2009 | CN101596240A Shuangdan micro pill and preparation method thereof |
| 12/09/2009 | CN101596197A Quick-release medicinal composition and preparation method thereof |
| 12/09/2009 | CN101596181A Medicinal composition containing dimeticone/simethicone |
| 12/09/2009 | CN101596179A Medicament composition for treating hyperammonemia and preparation method thereof |
| 12/09/2009 | CN101596174A Soft capsule and preparation method thereof |
| 12/09/2009 | CN101596173A Capsule capable of stabilizing acebrophylline |
| 12/09/2009 | CN101596172A Oral preparation capable of dosing fertility-controlling drugs by positioning at small intestine and production method thereof |
| 12/09/2009 | CN101596171A Tamsulosin sustained release tablet and preparation method thereof |
| 12/09/2009 | CN101596170A Trospium chloride slow-release tablet |
| 12/09/2009 | CN101596169A Chitosan nanoparticle for encapsulating adenosine triphosphate and preparation method thereof |
| 12/09/2009 | CN101596168A Lumbar anesthesia special local anaesthetic-glucose lyophilized powder injection as well as preparation method and package method thereof |
| 12/09/2009 | CN101596167A New preparation method of Ozagrel sodium powder injection |
| 12/09/2009 | CN101596166A Aspirin enteric-coated pellet |
| 12/09/2009 | CN101596165A Pantoprazole sodium enteric-coated pellet |
| 12/09/2009 | CN101596160A Alpha-asarone mixed micelle injectio and preparation method thereof |
| 12/09/2009 | CN101596159A New taxol injection and preparation method thereof |